---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-030391"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2023-08-28T23:59:59+00:00"
generated_at: "2026-06-11T02:54:48.427935+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ensysce shareholders elect directors, approve share increase, ratify auditor at annual meeting

## Summary
- Class II directors Bob Gower and Curtis Rosebraugh elected with 222,281 and 223,255 votes for, respectively.
- Amendment to 2021 Omnibus Incentive Plan approved, increasing authorized shares from 31,296 to 617,092 (202,246 for, 50,153 against).
- Ratification of Moss Adams LLP as independent auditor for FY 2023 approved with 1,631,139 votes for.

## SEC filing metadata
- accession: 0001493152-23-030391
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2023-08-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315223030391/0001493152-23-030391-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315223030391/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-030391
- JSON: https://secwatch.observer/filing/0001493152-23-030391.json
- Plain text: https://secwatch.observer/filing/0001493152-23-030391.txt

## Key facts
- Shareholder Votes
  Ensysce Biosciences, Inc. shareholders approved Amendment of the Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan to increase the aggregate number of shares that may be issued from 31,296 shares to 617,092 shares at the 2023-08-24 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-08-24
  source text: 202,246.08 50,153 1,500 1,484,119
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716947/000149315223030391/0001493152-23-030391-index.htm
- Shareholder Votes
  Ensysce Biosciences, Inc. shareholders approved Election of Class II Directors at the 2023-08-24 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-08-24
  source text: Bob Gower 222,281.08 20,963 10,655 1,484,119 Curtis Rosebraugh 223,255.08 11,605 9,039 1,484,119
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716947/000149315223030391/0001493152-23-030391-index.htm
- Shareholder Votes
  Ensysce Biosciences, Inc. shareholders approved Ratification of appointment of Moss Adams LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-08-24 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-08-24
  source text: Non-Votes 1,631,139.08 16,004 90,875 0 A quorum being present, votes properly cast “FOR” the proposal constituted a majority of votes cast on the matter, with “ABSTENTIONS”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716947/000149315223030391/0001493152-23-030391-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.